Type : |
Journal |
|
forskerhold : |
Vancouver - Children\'s and Women\'s Health Center of British Columbia |
Forfattere : |
Ensom MHH, Decarie D, Sheppard I. |
Titel : |
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration. |
Nummer : |
Can J Hosp Pharm ; 60, 3: 184-191. 2007 |
|
cotationvaleur : |
|
fysisk stabilitet : |
|
kemisk stabilitet : |
|
andre metoder : |
|
Kommentarer : |
|
Lister
Lansoprazole
|
![Protonpumpehæmmer Protonpumpehæmmer](./images/Picto.504.jpg) |
![Stabilitet i (vandige) opløsninger Stabilitet i (vandige) opløsninger](./images/Picto.591.jpg) |
![Glas Glas](./images/Picto.532.jpg) |
![Kapsel Kapsel](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
|
25°C |
![Lys Lys](./images/Picto.528.gif) |
91 |
![Dag Dag](./images/Picto.542.gif) |
|
|
![Stabilitet i (vandige) opløsninger Stabilitet i (vandige) opløsninger](./images/Picto.591.jpg) |
![Glas Glas](./images/Picto.532.jpg) |
![Kapsel Kapsel](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
25°C |
![Lys Lys](./images/Picto.528.gif) |
91 |
![Dag Dag](./images/Picto.542.gif) |
|
|
![Stabilitet i (vandige) opløsninger Stabilitet i (vandige) opløsninger](./images/Picto.591.jpg) |
![Glas Glas](./images/Picto.532.jpg) |
![Kapsel Kapsel](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
|
4°C |
![Beskyt mod lys Beskyt mod lys](./images/Picto.526.jpg) |
91 |
![Dag Dag](./images/Picto.542.gif) |
|
|
![Stabilitet i (vandige) opløsninger Stabilitet i (vandige) opløsninger](./images/Picto.591.jpg) |
![Glas Glas](./images/Picto.532.jpg) |
![Kapsel Kapsel](./images/Picto.10387.png) |
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
4°C |
![Beskyt mod lys Beskyt mod lys](./images/Picto.526.jpg) |
91 |
![Dag Dag](./images/Picto.542.gif) |
|
|
|
|